• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

什么是癌症恶病质综合征?历史视角。

What is cancer anorexia-cachexia syndrome? A historical perspective.

作者信息

Bennani-Baiti N, Walsh D

机构信息

Section of Palliative Medicine and Supportive Oncology, The Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.

出版信息

J R Coll Physicians Edinb. 2009 Sep;39(3):257-62.

PMID:20608345
Abstract

Cancer anorexia-cachexia syndrome (CACS) is a lethal but poorly defined involuntary wasting disorder. Loss of skeletal muscle and fat distinguishes it from starvation. Cachexia has been described as a clinical syndrome since ancient times, and the poor prognosis has long been acknowledged. In this article we have reviewed historical perspectives on cancer cachexia, and commented on modern definitions. In cancer cachexia, most historical descriptions included anorexia, wasting and a pale complexion. Other associated symptoms, such as fatigue, early satiety and taste changes, were inconsistently described. Newer descriptions have not significantly expanded the clinical picture.Today, there is still no consensus definition, hindering research on early diagnosis and effective therapy. The language descriptors used to characterise the syndrome are important. For example, the word 'cachexia' itself may mislead; perhaps cancer-related wasting syndrome is more accurate. Cancer anorexia-cachexia syndrome is a disorder associated with high morbidity and mortality, and deserves greater attention in both clinical and translational research.

摘要

癌症恶病质综合征(CACS)是一种致命但定义不清的非自主性消耗性疾病。骨骼肌和脂肪的减少使其有别于饥饿。恶病质自古以来就被描述为一种临床综合征,其预后不良早已为人所知。在本文中,我们回顾了关于癌症恶病质的历史观点,并对现代定义进行了评论。在癌症恶病质中,大多数历史描述包括厌食、消瘦和面色苍白。其他相关症状,如疲劳、早饱感和味觉改变,描述并不一致。更新的描述并未显著扩展临床表现。如今,仍然没有共识性定义,这阻碍了早期诊断和有效治疗的研究。用于描述该综合征的语言表述很重要。例如,“恶病质”这个词本身可能会产生误导;也许癌症相关消耗综合征更准确。癌症恶病质综合征是一种与高发病率和高死亡率相关的疾病,在临床和转化研究中都值得更多关注。

相似文献

1
What is cancer anorexia-cachexia syndrome? A historical perspective.什么是癌症恶病质综合征?历史视角。
J R Coll Physicians Edinb. 2009 Sep;39(3):257-62.
2
[Recent development in research and management of cancer anorexia-cachexia syndrome].[癌症恶病质综合征的研究与管理新进展]
Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9.
3
[The cachexia-anorexia syndrome among oncological patients].[肿瘤患者的恶病质-厌食综合征]
Gac Med Mex. 2008 Sep-Oct;144(5):435-40.
4
Cytokines and cancer anorexia cachexia syndrome.细胞因子与癌症恶病质综合征
Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10.
5
[Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].[医学中与喂养相关的疾病,特别提及癌症恶病质综合征]
Rinsho Byori. 2006 Oct;54(10):1044-51.
6
Cancer-related anorexia-cachexia syndrome.癌症相关的厌食-恶病质综合征
Clin J Oncol Nurs. 2010 Jun;14(3):283-7. doi: 10.1188/10.CJON.283-287.
7
Cancer anorexia - cachexia syndrome.癌症厌食-恶病质综合征
Acta Med Indones. 2012 Apr;44(2):154-62.
8
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.细胞因子活性在癌症相关性厌食/恶病质中的作用:醋酸甲地孕酮和醋酸甲羟孕酮的作用
Semin Oncol. 1998 Apr;25(2 Suppl 6):45-52.
9
Oxidative stress and wasting in cancer.癌症中的氧化应激与消瘦
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):449-56. doi: 10.1097/MCO.0b013e328122db94.
10
Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.治疗洞察:癌症恶病质综合征——当你只能消耗自身时。
Nat Clin Pract Oncol. 2005 Mar;2(3):158-65. doi: 10.1038/ncponc0112.

引用本文的文献

1
Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective.新兴的骨骼肌动态平衡和恶病质的发生机制:SUMO 的视角。
Cells. 2023 Feb 17;12(4):644. doi: 10.3390/cells12040644.
2
Targeting cancer cachexia: Molecular mechanisms and clinical study.靶向癌症恶病质:分子机制与临床研究
MedComm (2020). 2022 Sep 10;3(4):e164. doi: 10.1002/mco2.164. eCollection 2022 Dec.
3
Nutritional Interventions to Improve Cachexia Outcomes in Cancer-A Systematic Review.营养干预改善癌症恶病质结局的系统评价。
Medicina (Kaunas). 2022 Jul 21;58(7):966. doi: 10.3390/medicina58070966.
4
Assessment of Cancer-Associated Cachexia - How to Approach Physical Function Evaluation.癌症相关性恶病质的评估——如何进行身体功能评估
Curr Oncol Rep. 2022 Jun;24(6):751-761. doi: 10.1007/s11912-022-01258-4. Epub 2022 Mar 19.
5
Cancer Cachexia: Its Mechanism and Clinical Significance.癌症恶病质:发病机制及临床意义。
Int J Mol Sci. 2021 Aug 6;22(16):8491. doi: 10.3390/ijms22168491.
6
Insulin secretion decline in Walker-256 tumor-bearing rats is early, follows the course of cachexia, and is not improved by lixisenatide.Walker-256 荷瘤大鼠的胰岛素分泌下降发生较早,与恶病质的病程一致,利西那肽治疗不能改善。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):697-705. doi: 10.1007/s00210-020-02006-w. Epub 2020 Oct 31.
7
Ketone Bodies Attenuate Wasting in Models of Atrophy.酮体减轻萎缩模型中的消耗。
J Cachexia Sarcopenia Muscle. 2020 Aug;11(4):973-996. doi: 10.1002/jcsm.12554. Epub 2020 Apr 2.
8
Hepatic alterations during the development and progression of cancer cachexia.癌症恶病质发生和发展过程中的肝脏改变。
Appl Physiol Nutr Metab. 2020 May;45(5):500-512. doi: 10.1139/apnm-2019-0407. Epub 2019 Oct 16.
9
Gut disruption impairs rehabilitation in patients curatively operated for pancreaticoduodenal cancer - a qualitative study.肠道破坏会影响胰十二指肠癌根治性手术患者的康复——一项定性研究。
BMC Cancer. 2018 Oct 22;18(1):1017. doi: 10.1186/s12885-018-4933-1.
10
Are Four Simple Questions Able to Predict Weight Loss in Outpatients With Metastatic Cancer? A Prospective Cohort Study Assessing the Simplified Nutritional Appetite Questionnaire.
Nutr Cancer. 2016 Jul;68(5):743-9. doi: 10.1080/01635581.2016.1180412. Epub 2016 Jul 1.